Skip to main content
Log in

Risk Factors for Postoperative Pancreatic Fistulization Subsequent to Enucleation

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Introduction

Pancreatectomies increase the risk of postoperative pancreatic fistula (POPF) and pancreatic insufficiency. Pancreatic enucleation preserves pancreatic parenchyma, lowers the risk of pancreatic insufficiency, but may induce specific complications (tumor recurrence or pancreatic fistulization). The aim of this study was to determine the risk factors for POPF following a pancreatic enucleation.

Methods

A retrospective analysis was designed based on data from patients who underwent pancreatic enucleation in five university hospitals (1998–2008). The presence of a pancreatic fistula was determined according to the criteria of the International Study Group of Pancreatic Fistula (Bassi et al. Surgery 138:8–13, 2005).

Results

Fifty-two patients (mean age 52 years) were included. Histological analysis revealed 35 endocrine tumors (68.6 %), 6 mucinous and 2 serous cyst adenomas, 2 metastases of renal cancer, and 8 benign tumors. Nineteen patients (36.5 %) suffered postoperative complications including 14 POPF (27 %). Median postoperative hospital stay was 12.9 days; 9.1 days without POPF versus 29 days with POPF (p < 0.05). Size of the tumor, its location, histological differentiation, and use of somatostatin analogs were not predictors for POPF. We defined the cutoff for POPF at a distance of 2 mm from the main pancreatic duct based on 60 % risk (≤2 mm) versus 19 % (>2 mm) of POPF (p < 0.01). With a mean follow-up of 30.8 months, one patient experienced recurrence of the tumor. No patients exhibited a new onset of diabetes or pancreatic insufficiency.

Conclusion

Enucleation for resection of pancreatic tumors located at less than or equal to two 2 mm from the main pancreatic duct is a risk factor for POPF. Enucleation is a safe and effective treatment for benign or borderline pancreatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition Surgery 2005; 138:8–13.

    Article  PubMed  Google Scholar 

  2. Bassi C, Falconi M, Salvia R, Mascetta G, Molinari E, Pederzoli P. Management of complications after pancreaticoduodenectomy in a high volume centre: results on 150 consecutive patients. Dig Surg 2001; 18:453–457.

    Article  PubMed  CAS  Google Scholar 

  3. Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg 2008; 95:85–91.

    Article  PubMed  CAS  Google Scholar 

  4. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 2004; 18: 947–955.

    PubMed  Google Scholar 

  5. Crippa S, Bassi C, Salvia R, Falconi M, Butturini G, Pederzoli P. Enucleation of pancreatic neoplasms. Br J Surg 2007; 94:1254–1259

    Article  PubMed  CAS  Google Scholar 

  6. Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, Cai LX. Surgical Management of Patients With Insulinomas: Result of 292 Cases in a Single Institution. J Surg Oncol 2011; 103:169–74

    Article  PubMed  Google Scholar 

  7. Michael W. Müller, MD, Helmut Friess, MD, Jörg Kleeff, MD, Ulf Hinz, MSc, Moritz N. Wente, MD, Daniel Paramythiotis, MD, Pascal O. Berberat, MD, Güralp O. Ceyhan, MD, and Markus W. Büchler, MD An Option to Treat Benign Pancreatic Body Lesions. Ann Surg. 2006; 244: 909–920.

    Article  PubMed  Google Scholar 

  8. Sauvanet A., Surgical complications of pancreatectomy. J Chir 2008; 145:103–14.

    Article  CAS  Google Scholar 

  9. Bassi C. Middle segment pancreatectomy: a useful tool in the management of pancreatic neoplasms? J Gastrointest Surg 2007; 11:726–9.

    Article  PubMed  Google Scholar 

  10. Molinari E, Bassi C, Salvia R, Butturini G, Crippa S, Talamini G, Falconi M, Pederzoli P. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg. 2007; 246:281–7.

    Article  PubMed  Google Scholar 

  11. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien–Dindo Classification of Surgical Complications: Five-Year Experience Ann Surg: 2009; 250: 187–196

    Article  Google Scholar 

  12. Casadei R, Ricci C, Rega D, D’Ambra M, Pezilli R, Tomassetti P, Campana D, Nori F, Minni F. Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. Pancreas 2010:39:825–8

    Article  PubMed  Google Scholar 

  13. Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS, Rikkers LF. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg 2009:13:1692–8

    Article  PubMed  Google Scholar 

  14. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, and al.. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6:17–32.

    Article  PubMed  Google Scholar 

  15. Goasguen N, Bourrier A, Ponsot P, Bastien L, Lesurtel M, Prat F, Dousset B, Sauvanet A. Endoscopic management of pancreatic fistula after distal pancreatectomy and enucleation. AmJ Surg. 2009; 197:715–20.

    Article  Google Scholar 

  16. Lowy AM, Lee JE, Pisters PW, et al. Prospective, randomised trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg. 1997; 226: 632–641.

    Article  PubMed  CAS  Google Scholar 

  17. Marcus SG, Cohen H, Ranson JH. Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg. 1995; 221:635–648.

    Article  PubMed  CAS  Google Scholar 

  18. Fendrich V, Merz MK, Waldmann J, Langer P, HeverHagen AE, Dietzel K, Bartsch DK. Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgery. Dog Surg 2011; 28:263–9.

    Article  Google Scholar 

  19. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg 2006 ;93:264–275.

    Article  PubMed  CAS  Google Scholar 

  20. Fernández-Cruz L, Blanco L, Cosa R, Rendón H. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg. 2008; 32:904–17.

    Article  PubMed  Google Scholar 

  21. Mabrut JY, Fernandez-Cruz L, Azagra JS, et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 2005; 137:597–605

    Article  PubMed  Google Scholar 

  22. Isla A, Arbuckle JD, Kekis PB, Lim A, Jackson JE, Todd JF, Lynn J. Laparoscopic management of insulinomas. Br J Surg. 2009; 96:185–90.

    Article  PubMed  CAS  Google Scholar 

  23. Ramos-De la Medina A, Sarr MG. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J Hepatobiliary Pancreat Surg. 2006; 13:190–3.

    Article  PubMed  Google Scholar 

  24. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg. 2005; 92:1059–67.

    Article  PubMed  CAS  Google Scholar 

  25. Zeng Q, Zhang Q, Han S, Yu Z, Zheng M, Zhou M, Bai J, Jin R. Efficacity of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas. 2008; 36:18–25.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Mirallié.

Additional information

The institution from which the work originated is Clinique de Chirurgie Digestive et Endocrinienne, IMAD, University Hospital, Nantes, France.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brient, C., Regenet, N., Sulpice, L. et al. Risk Factors for Postoperative Pancreatic Fistulization Subsequent to Enucleation. J Gastrointest Surg 16, 1883–1887 (2012). https://doi.org/10.1007/s11605-012-1971-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-012-1971-x

Keywords

Navigation